Navigated and individual α-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia

CONCLUSION: Navigated αTMS to the left DLPFC reduced total, general psychopathological, and cognitive-disorganized symptoms of schizophrenia. These results provide evidence for the therapeutic efficacy of individual α-peak-frequency-guided rTMS in treatment-refractory schizophrenia.CLINICAL TRIAL REGISTRATION: NCT01941251; ClinicalTrials.gov.PMID:38428970 | DOI:10.1503/jpn.230063

Source: Journal of Psychiatry and Neuroscience - March 1, 2024 Category: Psychiatry Authors: Heli Tuppurainen Sara M äättä Mervi K önönen Petro Julkunen Hannu Kautiainen Soile Hyv ärinen Olli Vaurio Mikko Joensuu Matti Vanhanen Kati Aho-Mustonen Esa Mervaala Jari Tiihonen Source Type: research